MINAPHARM Pharmaceuticals (EGX: MIPH)
Egypt
· Delayed Price · Currency is EGP 161.54
0.00 (0.00%)
At close: Jan 29, 2025
MINAPHARM Pharmaceuticals Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -183.98 | -31.99 | 612.66 | 466.41 | 300.78 | 141.09 | Upgrade
|
| Depreciation & Amortization | 273.24 | 192.23 | 132.86 | 85.99 | 82.9 | 64.92 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.43 | 0.17 | - | -0.46 | - | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.14 | Upgrade
|
| Provision & Write-off of Bad Debts | 7.99 | 15.98 | -2.67 | -8.91 | 7.29 | -1.74 | Upgrade
|
| Other Operating Activities | 8.15 | -88.92 | 81.64 | 90.93 | 63.48 | 83.5 | Upgrade
|
| Change in Accounts Receivable | 168.74 | -147.28 | -168.51 | -22.41 | -81.04 | -64.87 | Upgrade
|
| Change in Inventory | -250.64 | -226.43 | -171.08 | -83.29 | -101.36 | 10.83 | Upgrade
|
| Change in Accounts Payable | 509.28 | 39.82 | 265.15 | -91.57 | 208.89 | -6.14 | Upgrade
|
| Change in Other Net Operating Assets | -369.94 | 352.1 | -188.28 | -229.4 | -43.82 | -21.93 | Upgrade
|
| Operating Cash Flow | 163.28 | 105.69 | 561.77 | 207.28 | 437.13 | 205.81 | Upgrade
|
| Operating Cash Flow Growth | -24.61% | -81.19% | 171.02% | -52.58% | 112.40% | -38.38% | Upgrade
|
| Capital Expenditures | -875.25 | -1,398 | -1,160 | -387.87 | -150.29 | -244.16 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.43 | 0.17 | - | 0.76 | 0.11 | 0 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.9 | -10.65 | -2.03 | -1.82 | -3.13 | -0.93 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 17 | Upgrade
|
| Other Investing Activities | -30.47 | 0 | 0 | -0.01 | 5.77 | 8.13 | Upgrade
|
| Investing Cash Flow | -608.19 | -1,409 | -1,162 | -388.94 | -147.55 | -219.95 | Upgrade
|
| Short-Term Debt Issued | - | 1,020 | 494.8 | - | - | 129.13 | Upgrade
|
| Long-Term Debt Issued | - | 356.15 | 636.62 | 425.73 | 119.24 | 9.23 | Upgrade
|
| Total Debt Issued | 1,819 | 1,376 | 1,131 | 425.73 | 119.24 | 138.36 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -205.3 | -49.74 | - | Upgrade
|
| Long-Term Debt Repaid | - | -25.52 | -12.15 | -11.86 | - | -38.04 | Upgrade
|
| Total Debt Repaid | -48.12 | -25.52 | -12.15 | -217.16 | -49.74 | -38.04 | Upgrade
|
| Net Debt Issued (Repaid) | 1,771 | 1,350 | 1,119 | 208.57 | 69.5 | 100.32 | Upgrade
|
| Repurchase of Common Stock | - | - | -69.63 | - | - | - | Upgrade
|
| Common Dividends Paid | -32.17 | -53.87 | -57.79 | -49.8 | -88.23 | -95.13 | Upgrade
|
| Other Financing Activities | 220.86 | 215.58 | 2.31 | -3.2 | -8 | 2.31 | Upgrade
|
| Financing Cash Flow | 1,959 | 1,512 | 994.16 | 155.57 | -26.73 | 7.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | 122.21 | 15.2 | 317.88 | -13.97 | -10.38 | -26.18 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -1.5 | - | - | Upgrade
|
| Net Cash Flow | 1,637 | 224.34 | 711.56 | -41.56 | 252.48 | -32.83 | Upgrade
|
| Free Cash Flow | -711.96 | -1,292 | -598.45 | -180.6 | 286.84 | -38.35 | Upgrade
|
| Free Cash Flow Margin | -16.10% | -33.21% | -16.53% | -6.01% | 12.15% | -1.87% | Upgrade
|
| Free Cash Flow Per Share | -64.35 | -116.81 | -52.16 | -14.69 | 23.33 | -3.12 | Upgrade
|
| Cash Interest Paid | 492.58 | 254.46 | 62.17 | 48.84 | 69.3 | 96.42 | Upgrade
|
| Cash Income Tax Paid | 32.88 | 132.95 | 182.39 | 154.77 | 63.23 | 9.42 | Upgrade
|
| Levered Free Cash Flow | - | -1,320 | -622.61 | -139.42 | 277.3 | -85.2 | Upgrade
|
| Unlevered Free Cash Flow | - | -1,161 | -583.75 | -108.9 | 320.61 | -24.94 | Upgrade
|
| Change in Net Working Capital | - | 178.82 | 157.31 | 276.42 | -54.38 | 29.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.